Inactivated influenza vaccine (Intanza®): patient group direction (PGD) template
PGD template to support the administration of intradermal inactivated influenza (Intanza®) vaccine in accordance with the national seasonal influenza vaccination programme.
Documents
Details
This PGD template supports the administration of intradermal inactivated influenza vaccine (Intanza®) as part of the national seasonal influenza vaccination programme.
It is valid from 1 September 2017 to 31 March 2018.
Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy or procedures to access authorised PGD documents.
This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.
Updates to this page
Published 24 September 2015Last updated 24 July 2017 + show all updates
-
Updated PGD template for the 2017 to 2018 influenza season.
-
Updated patient group direction template valid up to 31 March 2017.
-
First published.